Ology Bioservices to Present at the 30thAnnual Piper Jaffray Healthcare Conference
ALACHUA, Fla., November 20, 2018 – – Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that management will present at the 30thAnnual Piper Jaffray Healthcare conference, to be held at the Lotte New York Palace hotel, November 27-29.
James M. Matthew, chief financial officer, will present a corporate overview at 10:50am EST on November 29, including a discussion of the company’s position as a growing biologics CDMO, its proprietary technology platforms and expansion opportunities, as well as management’s strategic growth plan.
About Ology Bioservices
Ology Bioservices is a privately-held, full-service Contract Development Manufacturing Organization (CDMO) serving both government and commercial clients, specializing in biologic drug substance manufacturing, from early stage through commercial product. The company has 183,000 square feet of manufacturing, process development and QA/QC space in its state-of-the-art, Department of Defense Advanced Development and Manufacturing Facility in Florida. The company’s infrastructure provides unique services to its clients, including full regulatory support from preclinical through licensure, clinical trial operational support and bioanalytical testing, as well as cGMP manufacturing up to Biosafety Level 3 (BSL3). Ology Bioservices has 20 years of experience developing and manufacturing drugs and biologics for the U.S. Government, with over $500M in government contracts awarded over that time. The team at Ology Bioservices has decades of experience manufacturing, developing and licensing vaccines and protein/antibody therapeutics.
At Ology Bioservices, Inc.
Leslie Molony, Ph.D., 386-462-9663
Executive Director, Business Development
At Rx Communications Group, LLC
Melody A. Carey, 917-322-2571
President and Chief Executive Officer